It has been reported that pilocarpine inhibited the activity of glucose-6-phosphate dehydrogenase in the calf eye (1) and in pure yeast enzyme (2). In vivo studies showed that pilocarpine decreased the latency period and prolonged the narcosis produced by the injection of hexobarbital (3). Whether or not pilocarpine affects the hepatic drug me tabolism was investigated herein.
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Male rabbits, weighing 2.5-3.5 kg, were fasted approx. 12 hr with water available ad libitum, then sacrificed. The liver was homogenized with 3 volumes of 1.15 % KC1 solution in a Waring blendor and followed in a Potter-Elvehjem's teflon-glass homogenizer. A liver supernatant fraction was prepared by centrifugation of the homogenate at 10,700 x g for 40 min. This supernatant fraction was centrifuged at 105,000 x g for 1 hr and the firmly packed pellet of microsomes was resuspended in 1.15 % KCI solution containing 50 mM Tris-HC1 buffer, pH 7.4 and diluted to a concentration of 2 mg protein per ml. This suspension was utilized for recording difference spectra. The supernatant fraction, 2.5 ml, was mixed with a solution containing 1.5 pmole NADP, 25 mole G-6-P, 25 pmole MgCl, and 3 ,nmole substrates. The final volume made a total of 5.0 ml with 0.1 M sodium, potassium phosphate buffer, pH 7.4. Aqueous solutions of inhibitors were added in a final concentration to the mixture with volume of 0.2 ml.
Recently, inhibitory effects of nicotinamide on aminopyrine demethylase activities and aniline hydroxylase activities have been reported (4, 5). In preliminary experiments, the addition of 50 I-tmole of nicotinamide (final concentration: 10-2M) resulted in reduced activity by approx. 10 per cent in nicotine metabolism. All experiments described in this report were performed with nicotinamide-free media. Incubation was carried out at 37'C for 30 min under air in a Dubnoff metabolic shaker.
The rate of hydroxylation of hexobarbital was determined by the method of Cooper and Brodie (6) . Metabolism of nicotine was determined by measuring the radioactivity of 3H -nicotine remaining , in a liquid scintillation spectrometer (Aloka LSC-502) by the method reported by Hug (7) and described in details by Tsujimoto et al. (8) . As shown in Table 1 , pilocarpine was found to inhibit the metabolism of hexobarbital although concentration causing a 50 per cent inhibition (I5,) was higher than that obtained with SKF 525-A (2-diethylaminoethyl-2, 2-diphenylvalerate hydrochloride) and DPEA (2, 4-dichloro-6-phenylphenoxyethylamine hydrobromide), the most potent inhibitor of drug metabolism (13) . Consequently, it is suggested that the potentiating effect of pilo carpine on the narcosis produced by hexobarbital (3) may result in part from its inhibitory action on the drug metabolism in liver. The inhibitory action of pilocarpine on the me tabolism of nicotine was markedly more potent than that of hexobarbital. The extent of pilocarpine inhibition of aniline-hydroxylation was shown to be almost equal to that of hexobarbital-hydroxylation. DPEA showed potent inhibitory action of nicotine metabolism but the reaction of aniline-hydroxylation showed a marked resistance to DPEA. The inhibition produced by pilocarpine was approx. 7 times greater than that obtained with DPEA and proved to be the most potent inhibitor of aniline metabolism among the tested compounds. Imipramine, an antidepressant, bearing the inhibitory action of barbiturate metabolism (14) and SKF 525-A were shown to be less potent inhibitors of nicotine and aniline metabolism as compared to pilocarpine. It has been reported that various substances which were supplied as substrates and inhibitors of hepatic drug metabolism caused two 
